General Information of Drug (ID: DMAYPLE)

Drug Name
D-glyceraldehyde Drug Info
Synonyms
D(+)-Glyceraldehyde; D-(+)-Glyceraldehyde; D-2,3-dihydroxypropanal; D-2,3-dihydroxypropionaldehyde; D-aldotriose; D-glyceraldehyde; D-glycerose; Glyceraldehyde, D-; J-502403; Propanal, 2,3-dihydroxy-, (2R)-; Propanal, 2,3-dihydroxy-, (r)-; PubChem6338; Triose; (2R)-2,3-DIHYDROXYPROPANAL; (R)-2,3-Dihydroxypropanal; (R)-glyceraldehyde; (R);-2,3-Dihydroxypropanal; 41A680M0WB; 453-17-8; AC1L2WGP; AC1Q6A7Z; AK122382; EINECS 207-217-1; NSC 91534; Propanal, 2,3-dihydroxy-, (R)- (9CI); UNII-41A680M0WB; bmse000298
Cross-matching ID
PubChem CID
79014
ChEBI ID
CHEBI:17378
CAS Number
CAS 497-09-6
TTD Drug ID
DMAYPLE
INTEDE Drug ID
DR2085

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
Drug Status:
Approved Drug(s)
Drug(s) Metabolized By Triokinase/FMN cyclase (TKFC)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dihydroxyacetone DMM1LG2 Sunburn EJ40 Approved [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Triokinase/FMN cyclase (TKFC) Main DME DEX9ZJQ TKFC_HUMAN Substrate [1]

References

1 Bifunctional homodimeric triokinase/FMN cyclase: contribution of protein domains to the activities of the human enzyme and molecular dynamics simulation of domain movements. J Biol Chem. 2014 Apr 11;289(15):10620-36.